Adaptive licensing on the starting blocks as EMA calls for candidates
This article was originally published in Scrip
Executive Summary
Companies wanting to be part of Europe's progressive licensing experiment have the chance to do so after the European Medicines Agency called on firms to submit early-stage clinical development candidates for consideration as pilot cases under its new adaptive licensing project.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.